New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

Ujunwa C. Okoye-Okafor, Boris Bartholdy, Jessy Cartier, Enoch N. Gao, Beth Pietrak, Alan R. Rendina, Cynthia Rominger, Chad Quinn, Angela Smallwood, Kenneth J. Wiggall, Alexander J. Reif, Stanley J. Schmidt, Hongwei Qi, Huizhen Zhao, Gerard Joberty, Maria Faelth-Savitski, Marcus Bantscheff, Gerard Drewes, Chaya Duraiswami, Pat BradyArthur Groy, Swathi Rao Narayanagari, Iléana Antony-Debre, Kelly Mitchell, Heng Rui Wang, Yun Ruei Kao, Maximilian Christopeit, Luis Carvajal, Laura Barreyro, Elisabeth Paietta, Hideki Makishima, Britta Will, Nestor Concha, Nicholas D. Adams, Benjamin Schwartz, Michael T. McCabe, Jaroslav Maciejewski, Amit Verma, Ulrich Steidl

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clinically relevant IDH1 mutants. Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo. Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML. Our study provides proof of concept for the molecular and biological activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.

Original languageEnglish (US)
Pages (from-to)878-886
Number of pages9
JournalNature Chemical Biology
Volume11
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Allosteric Site
Mutation
Cytosine
Myeloid Cells
Leukemia
Stem Cells
DNA
Enzymes
Neoplasms

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. / Okoye-Okafor, Ujunwa C.; Bartholdy, Boris; Cartier, Jessy; Gao, Enoch N.; Pietrak, Beth; Rendina, Alan R.; Rominger, Cynthia; Quinn, Chad; Smallwood, Angela; Wiggall, Kenneth J.; Reif, Alexander J.; Schmidt, Stanley J.; Qi, Hongwei; Zhao, Huizhen; Joberty, Gerard; Faelth-Savitski, Maria; Bantscheff, Marcus; Drewes, Gerard; Duraiswami, Chaya; Brady, Pat; Groy, Arthur; Narayanagari, Swathi Rao; Antony-Debre, Iléana; Mitchell, Kelly; Wang, Heng Rui; Kao, Yun Ruei; Christopeit, Maximilian; Carvajal, Luis; Barreyro, Laura; Paietta, Elisabeth; Makishima, Hideki; Will, Britta; Concha, Nestor; Adams, Nicholas D.; Schwartz, Benjamin; McCabe, Michael T.; Maciejewski, Jaroslav; Verma, Amit; Steidl, Ulrich.

In: Nature Chemical Biology, Vol. 11, No. 11, 01.11.2015, p. 878-886.

Research output: Contribution to journalArticle

Okoye-Okafor, UC, Bartholdy, B, Cartier, J, Gao, EN, Pietrak, B, Rendina, AR, Rominger, C, Quinn, C, Smallwood, A, Wiggall, KJ, Reif, AJ, Schmidt, SJ, Qi, H, Zhao, H, Joberty, G, Faelth-Savitski, M, Bantscheff, M, Drewes, G, Duraiswami, C, Brady, P, Groy, A, Narayanagari, SR, Antony-Debre, I, Mitchell, K, Wang, HR, Kao, YR, Christopeit, M, Carvajal, L, Barreyro, L, Paietta, E, Makishima, H, Will, B, Concha, N, Adams, ND, Schwartz, B, McCabe, MT, Maciejewski, J, Verma, A & Steidl, U 2015, 'New IDH1 mutant inhibitors for treatment of acute myeloid leukemia', Nature Chemical Biology, vol. 11, no. 11, pp. 878-886. https://doi.org/10.1038/nchembio.1930
Okoye-Okafor, Ujunwa C. ; Bartholdy, Boris ; Cartier, Jessy ; Gao, Enoch N. ; Pietrak, Beth ; Rendina, Alan R. ; Rominger, Cynthia ; Quinn, Chad ; Smallwood, Angela ; Wiggall, Kenneth J. ; Reif, Alexander J. ; Schmidt, Stanley J. ; Qi, Hongwei ; Zhao, Huizhen ; Joberty, Gerard ; Faelth-Savitski, Maria ; Bantscheff, Marcus ; Drewes, Gerard ; Duraiswami, Chaya ; Brady, Pat ; Groy, Arthur ; Narayanagari, Swathi Rao ; Antony-Debre, Iléana ; Mitchell, Kelly ; Wang, Heng Rui ; Kao, Yun Ruei ; Christopeit, Maximilian ; Carvajal, Luis ; Barreyro, Laura ; Paietta, Elisabeth ; Makishima, Hideki ; Will, Britta ; Concha, Nestor ; Adams, Nicholas D. ; Schwartz, Benjamin ; McCabe, Michael T. ; Maciejewski, Jaroslav ; Verma, Amit ; Steidl, Ulrich. / New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. In: Nature Chemical Biology. 2015 ; Vol. 11, No. 11. pp. 878-886.
@article{83d4d72fb6ec447693eb344bd69d118c,
title = "New IDH1 mutant inhibitors for treatment of acute myeloid leukemia",
abstract = "Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clinically relevant IDH1 mutants. Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo. Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML. Our study provides proof of concept for the molecular and biological activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.",
author = "Okoye-Okafor, {Ujunwa C.} and Boris Bartholdy and Jessy Cartier and Gao, {Enoch N.} and Beth Pietrak and Rendina, {Alan R.} and Cynthia Rominger and Chad Quinn and Angela Smallwood and Wiggall, {Kenneth J.} and Reif, {Alexander J.} and Schmidt, {Stanley J.} and Hongwei Qi and Huizhen Zhao and Gerard Joberty and Maria Faelth-Savitski and Marcus Bantscheff and Gerard Drewes and Chaya Duraiswami and Pat Brady and Arthur Groy and Narayanagari, {Swathi Rao} and Il{\'e}ana Antony-Debre and Kelly Mitchell and Wang, {Heng Rui} and Kao, {Yun Ruei} and Maximilian Christopeit and Luis Carvajal and Laura Barreyro and Elisabeth Paietta and Hideki Makishima and Britta Will and Nestor Concha and Adams, {Nicholas D.} and Benjamin Schwartz and McCabe, {Michael T.} and Jaroslav Maciejewski and Amit Verma and Ulrich Steidl",
year = "2015",
month = "11",
day = "1",
doi = "10.1038/nchembio.1930",
language = "English (US)",
volume = "11",
pages = "878--886",
journal = "Nature Chemical Biology",
issn = "1552-4450",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

AU - Okoye-Okafor, Ujunwa C.

AU - Bartholdy, Boris

AU - Cartier, Jessy

AU - Gao, Enoch N.

AU - Pietrak, Beth

AU - Rendina, Alan R.

AU - Rominger, Cynthia

AU - Quinn, Chad

AU - Smallwood, Angela

AU - Wiggall, Kenneth J.

AU - Reif, Alexander J.

AU - Schmidt, Stanley J.

AU - Qi, Hongwei

AU - Zhao, Huizhen

AU - Joberty, Gerard

AU - Faelth-Savitski, Maria

AU - Bantscheff, Marcus

AU - Drewes, Gerard

AU - Duraiswami, Chaya

AU - Brady, Pat

AU - Groy, Arthur

AU - Narayanagari, Swathi Rao

AU - Antony-Debre, Iléana

AU - Mitchell, Kelly

AU - Wang, Heng Rui

AU - Kao, Yun Ruei

AU - Christopeit, Maximilian

AU - Carvajal, Luis

AU - Barreyro, Laura

AU - Paietta, Elisabeth

AU - Makishima, Hideki

AU - Will, Britta

AU - Concha, Nestor

AU - Adams, Nicholas D.

AU - Schwartz, Benjamin

AU - McCabe, Michael T.

AU - Maciejewski, Jaroslav

AU - Verma, Amit

AU - Steidl, Ulrich

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clinically relevant IDH1 mutants. Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo. Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML. Our study provides proof of concept for the molecular and biological activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.

AB - Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clinically relevant IDH1 mutants. Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo. Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML. Our study provides proof of concept for the molecular and biological activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.

UR - http://www.scopus.com/inward/record.url?scp=84945292899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945292899&partnerID=8YFLogxK

U2 - 10.1038/nchembio.1930

DO - 10.1038/nchembio.1930

M3 - Article

C2 - 26436839

AN - SCOPUS:84945292899

VL - 11

SP - 878

EP - 886

JO - Nature Chemical Biology

JF - Nature Chemical Biology

SN - 1552-4450

IS - 11

ER -